Business Wire

SBC Medical Launches SBC Wellness, a New Solution to Help Companies Deliver Additional Health Benefits and Enhance Employee Wellbeing

Share

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical,” or the “Company”), a global owner, operator and provider of management services and products to cosmetic treatment centers, today announced the launch of SBC Wellness, a wellness solution for corporate clients seeking to enhance their employee benefits programs. The Company believes that HR managers will regard SBC Wellness as an attractive addition to benefit offerings, which may strengthen employee recruitment and retention efforts, ultimately leading to healthier, happier, and more engaged workers. During the pre-launch period of this B2B initiative, SBC Medical successfully contracted with companies, and plans to gradually expand its deployment and forge new partnerships as brand awareness solidifies.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241115823816/en/

SBC Medical Launches SBC Wellness, a New Solution to Help Companies Deliver Additional Health Benefits and Enhance Employee Wellbeing (Photo: Business Wire)

Wellness Market Background
As competition in the labor market intensifies and lifestyle choices evolve, companies are finding it increasingly difficult to recruit and retain employees. Employee satisfaction (ES) is essential to recruiting top talent and preventing turnover and can help maintain a company’s competitiveness. According to a Research and Markets report titled “Japan Corporate Wellness Market Forecasts from 2023 to 2028,” the Japan corporate wellness industry is estimated to grow at a CAGR of 8.46% to reach US$7.423 billion in 2028 from US$4.204 billion in 2021. Corporate wellness in Japan is expected to show significant growth owing to the growing employee awareness of their mental and physical health coupled with the favorable efforts undertaken by the Japanese business community to improve employee morale and increase productivity. Also, implementing an employee wellness program can enhance a company's culture and working environment.” Reference: https://www.researchandmarkets.com/reports/5913092

New B2B Business
SBC Wellness will be available to customers beginning on November 18, 2024, and going forward, the Company plans to strengthen its B2B business and considers the offering of SBC Wellness employee benefit solution as a new growth area. In recent years, aesthetic medicine has come to meet the needs of people not only for "beauty" but also as an element that supports "health" and "personal lifestyle.” Therefore, incorporating cosmetic medicine as a part of employee benefit programs is attracting attention as an initiative that supports employee self-care, refreshment and motivation to work, which can also bolster the overall performance and brand image of the organization by inspiring users’ confidence in their work. The Company has designed this B2B growth initiative to meet the corporate goals of improving employee satisfaction and creating a rewarding work environment, and ultimately enhancing competitiveness.

About the SBC Wellness employee benefits solution
The SBC Wellness solution commences with a consultation, via mobile app or a dedicated phone and app, with a VIP concierge to review user concerns and provide information on treatment options and clinic selection. SBC Wellness aims to create a comfortable and accessible environment for a variety of users, including those new to cosmetic medicine. In addition to introducing clinics that match user preferences, SBC Wellness makes appointments on the user’s behalf, and coordinate the user’s schedule, while also checking for competitive pricing based on SBC Medical's available promotions. As part of this offering, SBC Medical plans to offer fertility treatment and egg freezing, supported by Roppongi Women's Clinic in SBC Medical's clinic network. Many of the largest U.S. companies offer a similar benefit. Additional premium services, such as personalized consultations for advanced skincare treatments and hair removal, will be available for corporate executives to enhance their professional presence and boost confidence in business settings.

SBC Medical Group Growth Strategy
SBC Medical believes this new service offering will create a new stage of growth through the strengthening of its B2B business. The Company strives to build a strong presence in a rapidly expanding market by developing employee benefit programs that support corporate human resource strategies. In addition to the Company’s existing franchise business for clinics, the Company intends to further accelerate the growth of the Company by focusing on the B2B business offering as a new long-term growth pillar. The Company has set a five year goal of achieving partnerships with 10% of the approximately 10,000 largest companies in Japan and expanding its current customer base (approximately 4 million) by a multiple of 1.5 times. The Company believes that achievement of these targets will create added value for various stakeholders, while demonstrating that the value SBC Medical provides is sought after not only by individuals but also by corporations. Furthermore, by expanding the Company’s corporate customer base, and attracting new loyal customers through the adoption of SBC's benefits programs among corporate employees, the Company aims to grow its revenue and enhance its profitability. SBC Medical intends to announce further progress and new partnerships as they become available through the official SBC Medical website.

Learn more about SBC Wellness: sbc-alliance@sbc.or.jp

About SBC Medical
SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics.
For more information, visit https://sbc-holdings.com/

Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241115823816/en/

Contacts

SBC Medical Group Holdings Incorporated
Hikaru Fukui / Head of Investor Relations
e-mail: ir@sbc-holdings.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Budweiser Kicks Off New “Celebration in the Making” Global Platform for FIFA Club World Cup 2025™6.6.2025 11:00:00 EEST | Press release

Today, Budweiser (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD) unveils its new global platform “Celebration in the Making” and full campaign details as the Official Global Beer Sponsor of the FIFA Club World Cup 2025™. This summer, as football supporters around the globe bring their energy to the groundbreaking tournament, Budweiser will be there to elevate celebrations at every stage – from the opening touch to the final whistle, and beyond. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606379419/en/ Budweiser Kicks Off New “Celebration in the Making” Global Platform for FIFA Club World Cup 2025™ To inspire celebrations from the start, Budweiser is officially kicking off the platform with a new film set to an iconic score, and announces the return of its acclaimed “Bring Home The Bud” campaign to deliver the ultimate prize of free beer for the winning club* and its supporters. Budweiser will also leverage exclusive FIFA-

SES Announces Appointment of New CFO6.6.2025 09:30:00 EEST | Press release

SES today announced its Board of Directors has appointed Elisabeth (Lisa) Pataki as Chief Financial Officer (CFO), effective 16 June 2025. Lisa is a progressive finance executive with over 20 years of experience at various publicly listed multi-national aerospace and defence companies with strong background in company transformation and investment strategies. She will succeed Sandeep Jalan who has been SES’s CFO since May 2020. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250605243814/en/ Lisa Pataki The SES Board acknowledges Sandeep’s contribution to SES and wishes him success in future endeavours. Lisa will work closely with Sandeep to ensure a smooth handover before he leaves on 31 July 2025. “I would like to thank Sandeep for his steadfast leadership over the last five years where he has driven continuous execution improvement and transformation while strengthening the company’s balance sheet with a competitive cost o

RAD 2025: Long-Term Data on Nemluvio ® (nemolizumab) Demonstrate its Favorable Safety Profile and Sustained and Increased Improvements in Itch and Skin Lesions in Patients With Atopic Dermatitis up to Two Years6.6.2025 08:00:00 EEST | Press release

Galderma (SIX: GALD) today announced two-year data from a new interim analysis of a long-term extension study investigating the safety and efficacy of Nemluvio in moderate-to-severe atopic dermatitis. The data show that Nemluvio is well tolerated, with no new safety signals identified, reinforcing its rapid onset of action and demonstrating sustained and increased improvements in symptoms including itch and skin lesions with prolonged treatment up to two years.1 These data will be presented in a late-breaker abstract at the Revolutionizing Atopic Dermatitis (RAD) Conference, taking place from June 6-7, 2025. “With Nemluvio now being launched in several countries, it’s so encouraging that we continue to see its robust evidence base expand. Long-term data is pivotal to this, highlighting the profound impact this innovative treatment can have in atopic dermatitis well into the future.” BALDO SCASSELLATI SFORZOLINI, M.D., PHD. GLOBAL HEAD OF RESEARCH & DEVELOPMENT GALDERMA Atopic dermatiti

BGO Announces US$5.1 Billion Capital Raise for Its Asia Value-Add Real Estate Strategy, Marking Largest Closed-End Fundraise in Firm’s History5.6.2025 23:00:00 EEST | Press release

BGO today announced the final close of BentallGreenOak Asia IV (“BGO Asia Fund IV” or the “Fund”), its flagship Asia-focused value-add real estate strategy, raising over US$5.1 billion in total capital commitments for the Fund and co-investment sidecars. The Fund represents the largest closed-end capital raise in BGO’s history, underscoring the firm’s history and reputation as a premier global real estate investment manager in Asian markets. BGO Asia Fund IV targets value-add opportunities in office, hospitality, and logistics assets across Japan, South Korea, Australia, and Singapore. Japan represents a central pillar of our investment strategy, driven by regulatory reforms and corporate governance shifts that are catalyzing an estimated US$3 trillion in non-core asset divestitures. “Japan is undergoing a profound transformation, and we see strong, sustained tailwinds across the region,” said Fred Schmidt, Managing Partner and Chairman of Asia, BGO. “Tokyo is one of the world’s larges

PIF and FIFA forge partnership for FIFA Club World Cup 2025™5.6.2025 20:00:00 EEST | Press release

PIF and FIFA today announced PIF as an official partner of FIFA Club World Cup 2025™, which will take place in the U.S. from June 14 to July 13, 2025. The partnership reflects FIFA and PIF’s shared vision to enable greater participation in sports by unlocking new opportunities, fostering innovation and engaging fans around the world. With a focus on youth, the partnership will provide opportunities for young people, supporting FIFA in its efforts to engage and inspire at a grassroots level. The new FIFA Club World Cup 2025™ marks a fresh chapter for club football on the global stage. It will feature 32 of the world’s top football clubs, bringing together champions from all six FIFA confederations for a month-long tournament in 11 cities across the U.S. Romy Gai, Chief Business Officer at FIFA, said:“We are delighted to welcome PIF as a partner of the FIFA Club World Cup 2025™. Together, we look forward to delivering a historic tournament that inspires and unites fans from around the wo

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye